Patterson Companies, Inc. (PDCO)
NASDAQ: PDCO · IEX Real-Time Price · USD
25.05
-0.68 (-2.64%)
At close: Jul 19, 2024, 4:00 PM
25.01
-0.04 (-0.16%)
Pre-market: Jul 20, 2024, 9:29 AM EDT
Patterson Companies Market Cap
Patterson Companies has a market cap or net worth of $2.20 billion as of July 22, 2024. Its market cap has decreased by -28.13% in one year.
Market Cap
2.20B
Enterprise Value
2.85B
1-Year Change
-28.13%
Ranking
Category
Stock Price
$25.05
Market Cap Chart
Since December 1, 1998, Patterson Companies's market cap has increased from $1.40B to $2.20B, an increase of 56.61%. That is a compound annual growth rate of 1.76%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Jul 19, 2024 | 2.20B | -16.61% |
Dec 29, 2023 | 2.64B | -3.11% |
Dec 30, 2022 | 2.72B | -4.92% |
Dec 31, 2021 | 2.86B | 0.07% |
Dec 31, 2020 | 2.86B | 45.87% |
Dec 31, 2019 | 1.96B | 5.01% |
Dec 31, 2018 | 1.87B | -45.51% |
Dec 29, 2017 | 3.43B | -14.72% |
Dec 30, 2016 | 4.02B | -10.63% |
Dec 31, 2015 | 4.50B | -9.37% |
Dec 31, 2014 | 4.96B | 14.07% |
Dec 31, 2013 | 4.35B | 16.93% |
Dec 31, 2012 | 3.72B | 13.66% |
Dec 30, 2011 | 3.27B | -12.99% |
Dec 31, 2010 | 3.76B | 9.73% |
Dec 31, 2009 | 3.43B | 50.33% |
Dec 31, 2008 | 2.28B | -51.98% |
Dec 31, 2007 | 4.75B | -3.93% |
Dec 29, 2006 | 4.94B | 6.99% |
Dec 30, 2005 | 4.62B | -22.53% |
Dec 31, 2004 | 5.96B | 36.54% |
Dec 31, 2003 | 4.37B | 46.36% |
Dec 31, 2002 | 2.98B | 7.74% |
Dec 31, 2001 | 2.77B | 21.24% |
Dec 29, 2000 | 2.28B | 59.03% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Janux Therapeutics | 2.32B |
Evolent Health | 2.29B |
Privia Health Group | 2.29B |
Amneal Pharmaceuticals | 2.23B |
Iovance Biotherapeutics | 2.23B |
CONMED | 2.19B |
AMN Healthcare Services | 2.17B |
Structure Therapeutics | 2.14B |